The PE Ratio as of November 2024 (TTM) for Adicet Bio, Inc. (ACET) is -0.53

According to Adicet Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.53. This represents a change of -51.01% compared to the average of -1.08 of the last 4 quarters.

Adicet Bio, Inc. (ACET) Historical PE Ratio (quarterly & annually)

How has ACET PE Ratio performed in the past?

The mean historical PE Ratio of Adicet Bio, Inc. over the last ten years is -31881.13. The current -0.53 PE Ratio has changed -99.83% with respect to the historical average. Over the past ten years (40 quarters), ACET's PE Ratio was at its highest in in the March 2022 quarter at 49.93. The PE Ratio was at its lowest in in the December 2016 quarter at -131.44.

Adicet Bio, Inc. (ACET) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Adicet Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adicet Bio, Inc. (ACET) Average PE Ratio

How has ACET PE Ratio performed in the past?

The current PE Ratio of Adicet Bio, Inc. (ACET) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Adicet Bio, Inc. (ACET) PE Ratio vs. Peers

How is ACET’s PE Ratio compared to its peers?

Adicet Bio, Inc.’s PE Ratio is greater than Edgewise Therapeutics, Inc. (-24.30), greater than Talaris Therapeutics, Inc. (-0.53), greater than Cullinan Oncology, Inc. (-5.10), less than Vor Biopharma Inc. (-0.48), greater than Tenaya Therapeutics, Inc. (-1.75), greater than Bicycle Therapeutics plc (-8.52), greater than IGM Biosciences, Inc. (-2.45), greater than Monte Rosa Therapeutics, Inc. (-5.83), greater than Stoke Therapeutics, Inc. (-6.11), greater than Aerovate Therapeutics, Inc. (-0.91), greater than Acrivon Therapeutics, Inc. Common Stock (-3.24), greater than Anebulo Pharmaceuticals, Inc. (-4.78), less than Agios Pharmaceuticals, Inc. (4.70), less than Homology Medicines, Inc. (-0.01), greater than Nkarta, Inc. (-1.63), greater than Pliant Therapeutics, Inc. (-3.91), greater than Alector, Inc. (-2.40), greater than Aadi Bioscience, Inc. (-1.01), greater than Keros Therapeutics, Inc. (-11.12),

Build a custom stock screener for Adicet Bio, Inc. (ACET) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adicet Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adicet Bio, Inc. (ACET) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adicet Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.